Sun Protection Factor (SPF) / UVA Protection Factor Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-02

Study Completion Date

2020-09-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the effectiveness of sunscreen products by determining its Sun Protection Factor (SPF) against UV-B and UV-A

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cost and Quality in Consumer Sunscreen Preferences

NCT04016441

Healthy

COMPLETED

Clinical Study to Evaluate the Sun Protection Factor (SPF) of Sunscreen Products

NCT05085327

Sunscreening Agents

COMPLETED NA

The Effect of Cosmetic Formulations on the Appearance of Grey Hair.

NCT07280676

Hair Graying

RECRUITING NA

Sunfiber and the Microbiota

NCT03722862

Diet Modification

COMPLETED NA

Efficacy and Safety of Unripe Bokbunja Extract on Improvement of Blood Cholesterol

NCT03649620

Blood Cholesterol

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sunscreen is intended to protect the skin from sun burn but since the amount of protection needed varies among individuals, sunscreen manufactures offer consumers difference levels of protection. These different levels of protection are expressed as a numerical value called the sun protection factor or SPF. The SPF is the ratio between the minimal erythema dose (MED) of sunscreen product of the protected skin and the MED of the unprotected skin. The minimal erythema dose in human skin is defined as the lowest ultraviolet B (UV-B) dose produces the first perceptible unambigous erythema with defined border appearing over most of the field of UVB exposure 16 - 24 hours after UVB exposure.

The UVA protection factor is the ratio between the Minimal Persistent Pigmentation Darkening Dose (MPPDD) of sunscreen product of the protected skin and the MPPDD of the unprotected skin. The threshold response will be taken as an unequivocal pigment darkening with distinct border which persisted for at least 2 hours.

The test products are Day Gel-0120-C and Day Gel-0120-D with active ingredients ethylhexyl methoxycinnamate, Diethylamino hydroxybenzoyl hexyl benzoate

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sunscreen Agents

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SPF evaluation

Healthy male or female subjects with Fitzpatrick Skin Type of II-IV were included in the SPF study

Group Type EXPERIMENTAL

Day Gel-0120

Intervention Type OTHER

Two milligrams of test article applied to the test area. The test products are Day Gel-0120C and Day Gel-0120-D. The products are applied together on the test area with

P5 Reference Standard (SPF 35 reference)

Intervention Type OTHER

The reference product is P5 according to ISO 24444:2019. The application of reference product is similar with test product.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Day Gel-0120

Two milligrams of test article applied to the test area. The test products are Day Gel-0120C and Day Gel-0120-D. The products are applied together on the test area with

Intervention Type OTHER

P5 Reference Standard (SPF 35 reference)

The reference product is P5 according to ISO 24444:2019. The application of reference product is similar with test product.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy male or female, 18-60 years of age
2. Fair skin with skin type II-IV of Fitzpatrick's skin type
3. Able to understand and comply to the investigators instruction.
4. Able to read, understand and sign up informed consent form.

Exclusion Criteria

1. Subject with a history of abnormal response to sunlight or those taking medication which might produce an abnormal response to sunlight
2. Subject exhibiting current sun burn, sun tan, uneven skin tone, or visible skin disease which might be confused with a reaction from the test material or which might interfere with evaluation of test results
3. Individuals who are under doctor's care
4. Female subjects who indicate that they are pregnant or nursing
5. Individuals with known hypersensitivity to any sunscreen products
6. Individuals accustomed to using tanning beds

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes